Response Pharmaceuticals
PrivateLast Round
Series B
Apr 23, 2024
Total Funding Raised
$8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Response Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for weight management and metabolic health, with a lead candidate, RDX-002, being evaluated for antipsychotic-induced weight gain and post-GLP-1 weight management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Response Pharmaceuticals Comparables
Compare Response Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aardark Therapeutics | 74% | |
| EktaH | 71% | |
| Corcept Therapeutics Incorporated | 69% | |
Response Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 23, 2024 | ||||
| Series A | Nov 21, 2022 |
Response Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Collage Venture Partners | Series A |
| Transhuman Capital | Series A |
| CrossWork | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 280% MoM, reaching 920.
Response Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Response Pharmaceuticals's valuation, stock price, and market status.